Shareholders' Deficit (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
|---|
| Shareholders' Deficit (Tables) [Line Items] |
|
| Schedule of Stock Option Activities |
During the three months ended March 31, 2024 and
2023, Series B preferred stock activity is as follows:
| |
|
For the Three Months Ended
March 31, 2024 |
|
|
For the Three Months Ended
March 31, 2023 |
|
| |
|
Number of
Shares |
|
|
Amount |
|
|
Number of
Shares |
|
|
Amount |
|
| Balance at beginning of period |
|
|
1,144 |
|
|
$ |
1,203,967 |
|
|
|
1,000 |
|
|
$ |
1,037,201 |
|
| Shares issued for accrued compensation |
|
|
312 |
|
|
|
312,000 |
|
|
|
144 |
|
|
|
144,000 |
|
| Shares issued for compensation |
|
|
50 |
|
|
|
50,000 |
|
|
|
- |
|
|
|
- |
|
| Shares and accrued dividends forfeited |
|
|
(120 |
) |
|
|
(127,640 |
) |
|
|
- |
|
|
|
- |
|
| Dividends accrued |
|
|
- |
|
|
|
6,894 |
|
|
|
- |
|
|
|
5,518 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period |
|
|
1,386 |
|
|
$ |
1,445,221 |
|
|
|
1,144 |
|
|
$ |
1,186,719 |
|
During the three months ended March 31, 2024 and
2023, Series C preferred stock activity is as follows:
| |
|
For the Three Months Ended
March 31, 2024 |
|
|
For the Three Months Ended
March 31, 2023 |
|
| |
|
Number of Shares |
|
|
Amount |
|
|
Number of Shares |
|
|
Amount |
|
| Balance at beginning of period |
|
|
15,150 |
|
|
$ |
1,621,160 |
|
|
|
17,290 |
|
|
$ |
1,803,731 |
|
| Conversion of Series C shares to common shares |
|
|
(400 |
) |
|
|
(40,000 |
) |
|
|
(1,014 |
) |
|
|
(101,400 |
) |
| Dividends accrued |
|
|
- |
|
|
|
7,455 |
|
|
|
- |
|
|
|
8,169 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period |
|
|
14,750 |
|
|
$ |
1,588,615 |
|
|
|
16,276 |
|
|
$ |
1,710,500 |
|
|
| Schedule of Activity Related to Non-Vested Shares |
The following table summarizes activity related
to non-vested shares:
| |
|
Number of
Non-Vested
Shares |
|
|
Weighted
Average
Grant Date
Fair Value |
|
| Non-vested, December 31, 2023 |
|
|
14,970,120 |
|
|
$ |
0.132 |
|
| Shares vested |
|
|
- |
|
|
|
- |
|
| Non-vested, March 31, 2024 |
|
|
14,970,120 |
|
|
$ |
0.132 |
|
|
| Warrant [Member] |
|
| Shareholders' Deficit (Tables) [Line Items] |
|
| Schedule of Stock Option Activities |
Warrant activities for the three months ended
March 31, 2024 are summarized as follows:
| |
|
Number of
Warrants |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
| Balance Outstanding December 31, 2023 |
|
|
34,000,000 |
|
|
$ |
0.011 |
|
|
|
2.73 |
|
|
$ |
- |
|
| Expired |
|
|
(200,000 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Balance Outstanding March 31, 2024 |
|
|
33,800,000 |
|
|
$ |
0.01 |
|
|
|
2.50 |
|
|
$ |
- |
|
| Exercisable, March 31, 2024 |
|
|
33,800,000 |
|
|
$ |
0.01 |
|
|
|
2.50 |
|
|
$ |
- |
|
|
| Stock Options [Member] |
|
| Shareholders' Deficit (Tables) [Line Items] |
|
| Schedule of Stock Option Activities |
Stock option activities for the three months ended
March 31, 2024 are summarized as follows:
| |
|
Number of
Options |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
| Balance Outstanding, December 31, 2023 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
2.43 |
|
|
|
- |
|
| Expired |
|
|
(1,100,000 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Balance Outstanding, March 31, 2024 |
|
|
7,345,698 |
|
|
$ |
0.44 |
|
|
|
2.53 |
|
|
$ |
- |
|
| Exercisable, March 31, 2024 |
|
|
7,345,698 |
|
|
$ |
0.44 |
|
|
|
2.53 |
|
|
$ |
- |
|
|